Merck & Co., Inc.
MRK
$79.29
$1.171.50%
NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 5.08B | 3.74B | 3.16B | 5.46B | 4.76B |
| Total Depreciation and Amortization | 1.06B | 1.11B | 1.15B | 1.07B | 919.00M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 75.00M | 448.00M | 2.41B | 128.00M | 791.00M |
| Change in Net Operating Assets | -3.71B | -1.86B | 2.58B | -1.01B | -3.38B |
| Cash from Operations | 2.50B | 3.45B | 9.29B | 5.64B | 3.09B |
| Capital Expenditure | -1.33B | -937.00M | -783.00M | -791.00M | -861.00M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -2.00M | -3.35B | 0.00 | -746.00M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -159.00M | -505.00M | 283.00M | -278.00M | 231.00M |
| Cash from Investing | -1.49B | -1.44B | -3.85B | -1.07B | -1.38B |
| Total Debt Issued | -- | 0.00 | -1.00M | 3.60B | -- |
| Total Debt Repaid | -2.50B | -539.00M | 0.00 | 0.00 | -751.00M |
| Issuance of Common Stock | 19.00M | 12.00M | 5.00M | 73.00M | 87.00M |
| Repurchase of Common Stock | -1.16B | -489.00M | -444.00M | -251.00M | -122.00M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -2.05B | -1.95B | -1.95B | -1.99B | -1.95B |
| Other Financing Activities | -60.00M | -42.00M | -32.00M | -220.00M | -78.00M |
| Cash from Financing | -5.76B | -3.01B | -2.43B | 1.22B | -2.81B |
| Foreign Exchange rate Adjustments | 156.00M | -367.00M | 294.00M | -82.00M | -138.00M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -4.59B | -1.37B | 3.32B | 5.70B | -1.24B |